IDIBELL is looking for an Expert in Biomarkers for Neuroscience
IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.
IDIBELL is located in L’Hospitalet de Llobregat, south of Barcelona. It is a member of the Campus of International Excellence of the University of Barcelona (HUBc) and Research Centers of Catalonia (CERCA). In 2009, it became one of the first five Spanish research centers accredited as a health research institute by the Health Institute Carlos III. In 2015, the European Commission recognized IDIBELL with the ‘HR Excellence in Research’ award, which identifies IDIBELL as a provider and supporter of a stimulating research work environment.
About the research group
The Neuropharmacology and Pain Research Group of the Institut d”Investigació Biomèdica de Bellvitge (IDIBELL) (http://www.ub.edu/neuropharmpain/) is focused in the study of G protein-coupled receptors (GPCRs) biology and pharmacology in neurological diseases, including Parkinson’s disease (PD). Indeed, our recent research has focused on assessing the role of GPR37, an orphan GPCR, in PD, thus payig special attention to its cell surface targeting and function.
About the role
To develop and validate a novel enzyme-linked immunosorbent assay (ELISA) to quantify ecto-GPR37 in biofluids, thus allowing the identification of ecto-GPR37 as a measurable indicator in the neuropathology of PD. Special interest will be posed in evaluating the presence of ecto-GPR37 in plasma, to this end a SIMOA-based assay will be engineered.
- Biomarker validation
Education and training
- BSc in Biochemistry (or related)
- PhD in Biomedicine/Neurosciences
- Basic biochemical techniques
- Protein production
- ELISA development
- Good command of the English language
We will value, but not required
- SIMOA Technology
- Nº of positions: 1
- Start date: 01/06/2021
- Contract duration: 1 year
- Estimated annual gross salary: salary is commensurate with qualifications and consistent with our pay ranges
We provide a highly stimulating working environment with state-of-the-art infrastructures, and unique professional development opportunities.
IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTM-R) practices.
We offer and promote diverse and inclusive working conditions and applicants are made free from any discrimination based on age, national original, gender, religion, disability, sexual orientation or gender identity.
We are committed to reconciliation of work and family life such as employees can benefit from flexible working hours.
All applications must include the following:
- A motivation letter addressed to Francisco Ciruela
- A CV including contact information
- Contact details of two referee
- Pre-selection: The pre-selection process will consist on an eligibility check based on qualifications and expertise reflected on the candidate’s CV.
- Interview: Best positioned, pre-selected candidates may be called to arrange an interview. Candidates will be interviewed by the hiring manager and an ad hoc selection panel.
- Formal offer letter: Once identified, the People Management Unit will send a job offer to the successful candidate indicating start date, salary, working conditions, and any additional relevant details.
Deadline: Please submit your application by 12 May 2021.
Data protection notice
IDIBELL ensures that applicants’ personal data are processed as required by the EU General Data Protection Regulation (GDPR) and Spanish Law 3/2018 on Data Protection. Personal data is processed solely for the purpose of the selection procedure.
The ‘HR Excellence in Research’ award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).
This contract has received funding from The Michael J. Fox Foundation for Parkinson’s Research (Grant ID: MJFF-001051)